Physician profile
Julia Feldman
NPI 1164076899
$6,674.45
in general payments reported to CMS, 2019-2025
35 companies · $1,677 in 2025
The $1,677 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,236 · 2022: $1,200 · 2023: $1,371 · 2024: $1,190 · 2025: $1,677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,238.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,515.85 | 2021-2025 | Relistor |
| Abbvie INC. | $1,336.34 | 2021-2025 | |
| Valinor Pharma, LLC | $567.05 | 2023-2025 | Movantik |
| Collegium Pharmaceutical, INC. | $380.29 | 2021-2025 | Xtampza |
| Pfizer INC. | $313.93 | 2021-2025 | |
| Azurity Pharmaceuticals, INC. | $273.83 | 2023-2025 | Horizant, Horizant |
| Lilly USA, LLC | $191.34 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $177.27 | 2022 | |
| Averitas Pharma INC. | $174.16 | 2023-2025 | Qutenza |
| Arbor Pharmaceuticals, INC. | $169.05 | 2021-2022 | |
| Indivior INC. | $165.20 | 2021-2024 | Sublocade |
| Novo Nordisk INC | $146.75 | 2022-2025 | Wegovy |
| Hikma Pharmaceuticals USA | $115.90 | 2021-2022 | |
| Lundbeck LLC | $103.33 | 2024-2025 | Vyepti |
| Redhill Biopharma INC. | $102.60 | 2021-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $101.00 | 2024-2025 | Prialt |
| Vertex Pharmaceuticals Incorporated | $85.25 | 2024-2025 | |
| Depuy Synthes Sales INC. | $82.55 | 2022-2023 | Monovisc, Orthovisc |
| Allergan, INC. | $76.80 | 2021-2022 | |
| Bioventus LLC | $68.43 | 2021-2025 | Supartz Fx Sodium Hyaluronate |
| Medtronic, INC. | $59.95 | 2021-2023 | Synchromedii |
| Biohaven Pharmaceuticals, INC. | $49.25 | 2021 | |
| Scilex Pharmaceuticals INC. | $47.47 | 2022 | |
| Si-Bone, INC. | $46.18 | 2023 | |
| Vertos Medical, INC. | $44.24 | 2021 | |
| Novartis Pharmaceuticals Corporation | $39.61 | 2021 | |
| Spinal Simplicity, LLC | $36.80 | 2023-2025 | Ha Minuteman G3-R |
| Orexo US, INC. | $34.30 | 2021 | |
| Painteq LLC | $32.91 | 2022 | |
| Fidia Pharma USA INC. | $29.99 | 2022 | |
| Spr Therapeutics, INC | $24.45 | 2024 | Sprint Pns System |
| Relievant Medsystems, INC. | $23.57 | 2021 | |
| Saluda Medical Americas, INC. | $23.03 | 2024 | Evoke |
| Nevro Corp. | $22.21 | 2024 | Senza |
| Teva Pharmaceuticals USA, INC. | $13.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Feldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.